Pokeweed Antiviral Inhibits HIV

Article

WESTPORT, Conn-Researchers from the Parker Hughes Institute in St. Paul, Minn, have found that pokeweed antiviral protein (PAP) inhibits HIV-1without injuring sperm or female genital tract epithelial cells.

The nonspermicidal antiretroviral treatment could allow pregnancy of women in couples where the male partner is HIV-positive without putting the mother and fetus at risk of contracting the viral infection.

PAP comes from purified leaves of Phytolacca Americana and has shown broad antiviral activity against a number of pathogenic viruses. It has shown to protect against HIV-1, herpes simplex virus, and cytomegalovirus.

The discovery is important because it is a potent antiviral agent that has no adverse effects on either sperm function or female genital-tract epithelial cells, making it a fitting ingredient for spermicides.

PAP is said to directly inactivate the virus as well as interrupt the virus life cycle under conditions that do not affect sperm function.

Information from: www.hivandhepatitis.com

Newsletter

Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.

Recent Videos
Bug of the Month
David J. Weber, MD, MPH, president of the Society for Healthcare Epidemiology of America
Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio
© 2025 MJH Life Sciences

All rights reserved.